rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Sensus Healthcare, Inc.

SRTS · Nasdaq

Health CareMedical DevicesNot moving yet

SRTS stood above a rising 150-day average in 5 of the last 52 weekly readings, and has been out of that trend for the last 26 weeks. It is 16.5% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 26
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$1.3M
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
36 (-1)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 5 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$1.1MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months17
Sale orders, 12 months0
Buyers · sellers3 · 0
WhoDidSharesTraded
Eric SachettaDirectorbought27,304at $3.5431 Aug 2026filed 31 Aug 2026
Eric SachettaDirectorbought37,537at $3.4428 Aug 2026filed 31 Aug 2026
Eric SachettaDirectorbought10,925at $3.1827 Aug 2026filed 28 Aug 2026
Eric SachettaDirectorbought9,708at $3.2926 Aug 2026filed 28 Aug 2026
Eric SachettaDirectorbought34,697at $3.2524 Aug 2026filed 25 Aug 2026
Eric SachettaDirectorbought7,000at $3.2521 Aug 2026filed 24 Aug 2026
Joseph C. SardanoCHIEF EXECUTIVE OFFICERbought20,000at $3.0220 Aug 2026filed 24 Aug 2026
Eric SachettaDirectorbought24,000at $3.1320 Aug 2026filed 24 Aug 2026
Eric SachettaDirectorbought1,500at $3.3412 May 2026filed 12 May 2026
Eric SachettaDirectorbought2,000at $3.8124 Feb 2026filed 26 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders36-1 on the quarter
New · exited4 · 5
Reported value$10.7M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Pacific Ridge Capital Partners, LLCreduced · filed 12 Aug 2026789,675$2.4M-6,397−0.8%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026660,402$2.0M+12,177+1.9%
DIMENSIONAL FUND ADVISORS LPreduced · filed 11 Aug 2026316,121$955K-71,271−18.4%
Divisadero Street Capital Management, LPreduced · filed 14 Aug 2026278,485$841K-7,593−2.7%
RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 2026242,334$732K-9,900−3.9%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026154,152$466K-11,398−6.9%
UBS Group AGreduced · filed 13 Aug 2026152,573$461K-20,297−11.7%
Sachetta, LLCadded · filed 15 Jul 2026152,008$459K+1,500+1.0%
Greenline Wealth Management LLCunchanged · filed 23 Jul 2026128,774$389K00.0%
North Star Investment Management Corp.unchanged · filed 28 Jul 2026125,586$379K00.0%
31 Mar 2023 – 30 Jun 2026
354758Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Eric Sachetta Company insiderDirector · last 31 Aug 202611 · 0
Joseph C. Sardano Company insiderCHIEF EXECUTIVE OFFICER · last 20 Aug 20266 · 44
Michael Sardano Company insiderPRESIDENT AND GENERAL COUNSEL · last 12 Dec 20259 · 1
Javier Rampolla Company insiderCHIEF FINANCIAL OFFICER · last 10 Feb 20251 · 1
Anthony Benedict Petrelli Company insiderDirector · last 17 Dec 20240 · 0
Megan Cornish Company insiderDirector · last 17 Dec 20240 · 0
William H. McCall Company insiderDirector · last 17 Dec 202411 · 2
John Heinrich Company insiderDirector · last 20 May 20242 · 2
Magdalena Martinez Company insiderCHIEF OPERATING OFFICER · last 19 Dec 20230 · 0
Samuel O'Rear Company insiderDirector · last 9 May 20232 · 2
Nicolas Soro Company insiderCHIEF OPERATING OFFICER · last 9 Mar 20220 · 1
Stephen Brad Cohen Company insiderEXECUTIVE VICE PRESIDENT · last 17 Dec 20210 · 39

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202543.2%
Operating profit marginFY 2025 · to 31 Dec 2025-37.5%
Free cash flow marginFY 2025 · to 31 Dec 20251.2%
Return on capital employedFY 2025 · to 31 Dec 2025-21.3%
Interest coverFY 2025 · to 31 Dec 2025-15.09×
Research spendFY 2025 · to 31 Dec 202528.3%
Share count trendFY 2025 · to 24 Feb 2026-0.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$22.1M
Free cash flowFY 2025 · to 31 Dec 2025$332K

Analyst forecasts

No analyst forecasts yet.